Neurological

Spotlight

Building an mRNA giant: Moderna’s 7 priorities for 2023 BioNTech and OncoC4 team up on novel checkpoint antibody Sandoz gets green light from US FDA for high strength Humira biosimilar FDA committee agrees Biogen’s ALS therapy could have ‘clinical benefit’ ‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate

Follow us

Most popular News

• 1 Novartis releases long-term Zolgensma data
• 2 Pfizer to acquire Seagen for $43bn: ‘Together, we seek to accelerate the next generation of cancer breakthroughs’
• 3 SVB collapse: As biotechs report exposure to lender, US government moves to guarantee deposits and HSBC buys UK unit
• 4 Novartis and Biogen exit deals with Sangamo
• 5 Building an mRNA giant: Moderna’s 7 priorities for 2023

Products

View more

• eBook: mRNA prospects and scale-up solutions Thermo Fisher Scientific - Biosciences | Download Insight Guide
• Impurity profiling and analysis of TheraPure GMP nucleotides Thermo Fisher Scientific - Biosciences | Download Technical / White Paper
• Create Better Biologic Treatments with Catalent Catalent | Download Product Brochure
• Trends in Biopharmaceutical Raw Material Selection Actylis – The Partner of Choice | Watch Business Advice

Webinars

On-demand webinars

• Bioprocessing 4.0 Webinar
• Delivery Systems for Biologics Webinar
• Cell and gene therapies: How can their promise be realized? Webinar
• Manufacture of vaccines (Part II) Webinar
• Innovations In Drug Delivery Webinar

Featured Suppliers

All

• Actylis – The Partner of Choice
• Altasciences
• Separation and Purification
• Sumitomo Chemical Europe
• Thermo Fisher Scientific - Biosciences